Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape
| dc.contributor.author | Wibmer, Constantinos Kurt | |
| dc.contributor.author | Gorman, Jason | |
| dc.contributor.author | Ozorowski, Gabriel | |
| dc.contributor.author | Bhiman, Jinal N | |
| dc.contributor.author | Sheward, Daniel J | |
| dc.contributor.author | Joyce, M Gordon | |
| dc.contributor.author | Asokan, Mangai | |
| dc.contributor.author | Burton, Dennis R | |
| dc.contributor.author | Connors, Mark | |
| dc.contributor.author | Abdool Karim, Salim S | |
| dc.contributor.author | Mascola, John R | |
| dc.contributor.author | Robinson, James E | |
| dc.contributor.author | Ward, Andrew B | |
| dc.contributor.author | Kwong, Peter D | |
| dc.contributor.author | Morris, Lynn | |
| dc.contributor.author | Moore, Penny L | |
| dc.date.accessioned | 2021-10-08T07:15:54Z | |
| dc.date.available | 2021-10-08T07:15:54Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | A comprehensive understanding of the regions on HIV-1 envelope trimers targeted by broadly neutralizing antibodies may contribute to rational design of an HIV-1 vaccine. We previously identified a participant in the CAPRISA cohort, CAP248, who developed trimer-specific antibodies capable of neutralizing 60% of heterologous viruses at three years post-infection. Here, we report the isolation by B cell culture of monoclonal antibody CAP248-2B, which targets a novel membrane proximal epitope including elements of gp120 and gp41. Despite low maximum inhibition plateaus, often below 50% inhibitory concentrations, the breadth of CAP248-2B significantly correlated with donor plasma. Site-directed mutagenesis, X-ray crystallography, and negative-stain electron microscopy 3D reconstructions revealed how CAP248-2B recognizes a cleavage-dependent epitope that includes the gp120 C terminus. While this epitope is distinct, it overlapped in parts of gp41 with the epitopes of broadly neutralizing antibodies PGT151, VRC34, 35O22, 3BC315, and 10E8. CAP248-2B has a conformationally variable paratope with an unusually long 19 amino acid light chain third complementarity determining region. Two phenylalanines at the loop apex were predicted by docking and mutagenesis data to interact with the viral membrane. Neutralization by CAP248-2B is not dependent on any single glycan proximal to its epitope, and low neutralization plateaus could not be completely explained by N- or O-linked glycosylation pathway inhibitors, furin co-transfection, or pre-incubation with soluble CD4. Viral escape from CAP248-2B involved a cluster of rare mutations in the gp120-gp41 cleavage sites. Simultaneous introduction of these mutations into heterologous viruses abrogated neutralization by CAP248-2B, but enhanced neutralization sensitivity to 35O22, 4E10, and 10E8 by 10-100-fold. Altogether, this study expands the region of the HIV-1 gp120-gp41 quaternary interface that is a target for broadly neutralizing antibodies and identifies a set of mutations in the gp120 C terminus that exposes the membrane-proximal external region of gp41, with potential utility in HIV vaccine design. | |
| dc.identifier.apacitation | Wibmer, C. K., Gorman, J., Ozorowski, G., Bhiman, J. N., Sheward, D. J., Joyce, M. G., ... Moore, P. L. (2017). Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. <i>PLoS Pathogens</i>, 13(1), e1006074 - 177. http://hdl.handle.net/11427/34718 | en_ZA |
| dc.identifier.chicagocitation | Wibmer, Constantinos Kurt, Jason Gorman, Gabriel Ozorowski, Jinal N Bhiman, Daniel J Sheward, M Gordon Joyce, Mangai Asokan, et al "Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape." <i>PLoS Pathogens</i> 13, 1. (2017): e1006074 - 177. http://hdl.handle.net/11427/34718 | en_ZA |
| dc.identifier.citation | Wibmer, C.K., Gorman, J., Ozorowski, G., Bhiman, J.N., Sheward, D.J., Joyce, M.G., Asokan, M. & Burton, D.R. et al. 2017. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. <i>PLoS Pathogens.</i> 13(1):e1006074 - 177. http://hdl.handle.net/11427/34718 | en_ZA |
| dc.identifier.issn | 1553-7366 | |
| dc.identifier.issn | 1553-7374 | |
| dc.identifier.ris | TY - Journal Article AU - Wibmer, Constantinos Kurt AU - Gorman, Jason AU - Ozorowski, Gabriel AU - Bhiman, Jinal N AU - Sheward, Daniel J AU - Joyce, M Gordon AU - Asokan, Mangai AU - Burton, Dennis R AU - Connors, Mark AU - Abdool Karim, Salim S AU - Mascola, John R AU - Robinson, James E AU - Ward, Andrew B AU - Kwong, Peter D AU - Morris, Lynn AU - Moore, Penny L AB - A comprehensive understanding of the regions on HIV-1 envelope trimers targeted by broadly neutralizing antibodies may contribute to rational design of an HIV-1 vaccine. We previously identified a participant in the CAPRISA cohort, CAP248, who developed trimer-specific antibodies capable of neutralizing 60% of heterologous viruses at three years post-infection. Here, we report the isolation by B cell culture of monoclonal antibody CAP248-2B, which targets a novel membrane proximal epitope including elements of gp120 and gp41. Despite low maximum inhibition plateaus, often below 50% inhibitory concentrations, the breadth of CAP248-2B significantly correlated with donor plasma. Site-directed mutagenesis, X-ray crystallography, and negative-stain electron microscopy 3D reconstructions revealed how CAP248-2B recognizes a cleavage-dependent epitope that includes the gp120 C terminus. While this epitope is distinct, it overlapped in parts of gp41 with the epitopes of broadly neutralizing antibodies PGT151, VRC34, 35O22, 3BC315, and 10E8. CAP248-2B has a conformationally variable paratope with an unusually long 19 amino acid light chain third complementarity determining region. Two phenylalanines at the loop apex were predicted by docking and mutagenesis data to interact with the viral membrane. Neutralization by CAP248-2B is not dependent on any single glycan proximal to its epitope, and low neutralization plateaus could not be completely explained by N- or O-linked glycosylation pathway inhibitors, furin co-transfection, or pre-incubation with soluble CD4. Viral escape from CAP248-2B involved a cluster of rare mutations in the gp120-gp41 cleavage sites. Simultaneous introduction of these mutations into heterologous viruses abrogated neutralization by CAP248-2B, but enhanced neutralization sensitivity to 35O22, 4E10, and 10E8 by 10-100-fold. Altogether, this study expands the region of the HIV-1 gp120-gp41 quaternary interface that is a target for broadly neutralizing antibodies and identifies a set of mutations in the gp120 C terminus that exposes the membrane-proximal external region of gp41, with potential utility in HIV vaccine design. DA - 2017 DB - OpenUCT DP - University of Cape Town IS - 1 J1 - PLoS Pathogens LK - https://open.uct.ac.za PY - 2017 SM - 1553-7366 SM - 1553-7374 T1 - Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape TI - Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape UR - http://hdl.handle.net/11427/34718 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/34718 | |
| dc.identifier.vancouvercitation | Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Joyce MG, et al. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. PLoS Pathogens. 2017;13(1):e1006074 - 177. http://hdl.handle.net/11427/34718. | en_ZA |
| dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | |
| dc.publisher.faculty | Faculty of Health Sciences | |
| dc.source | PLoS Pathogens | |
| dc.source.journalissue | 1 | |
| dc.source.journalvolume | 13 | |
| dc.source.pagination | e1006074 - 177 | |
| dc.source.uri | https://dx.doi.org/10.1371/journal.ppat.1006074 | |
| dc.subject.other | Biology and Life Sciences | |
| dc.subject.other | Physiology | |
| dc.subject.other | Immune Physiology | |
| dc.subject.other | Antibodies | |
| dc.subject.other | Medicine and Health Sciences | |
| dc.subject.other | Immunology | |
| dc.subject.other | Immune System Proteins | |
| dc.subject.other | Biochemistry | |
| dc.subject.other | Proteins | |
| dc.subject.other | Microbiology | |
| dc.subject.other | Medical Microbiology | |
| dc.subject.other | Microbial Pathogens | |
| dc.subject.other | Viral Pathogens | |
| dc.subject.other | Immunodeficiency Viruses | |
| dc.subject.other | HIV | |
| dc.subject.other | HIV-1 | |
| dc.subject.other | Pathology and Laboratory Medicine | |
| dc.subject.other | Pathogens | |
| dc.subject.other | Organisms | |
| dc.subject.other | Viruses | |
| dc.subject.other | Biology and life sciences | |
| dc.subject.other | RNA viruses | |
| dc.subject.other | Retroviruses | |
| dc.subject.other | Lentivirus | |
| dc.subject.other | Physical Sciences | |
| dc.subject.other | Physics | |
| dc.title | Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape | |
| dc.type | Journal Article | |
| uct.type.publication | Research | |
| uct.type.resource | Journal Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- WibmerConstantinosKurt_StructureRecogn_2017.pdf
- Size:
- 2.97 MB
- Format:
- Adobe Portable Document Format
- Description: